PD-L1 expression associated with better response to EGFR tyrosine kinase inhibitors

Cancer Biol Med. 2015 Jun;12(2):71-3. doi: 10.7497/j.issn.2095-3941.2015.0026.

¹ 1 Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona 08916, Spain ; 2 Germans Trias i Pujol Health Sciences Institute and Hospital, Campus Can Ruti, Badalona 08916, Spain ; 3 Instituto Oncológico Dr Rosell, Quiron Dexeus University Hospital, Barcelona 08028, Spain ; 4 Pangaea Biotech, Barcelona 08028, Spain ; 5 Molecular Oncology Research (MORe) Foundation, Barcelona 08028, Spain ; 6 Thoracic Oncology Unit, Department of Medical Oncology, Catalan Institute of Oncology, L'Hospitalet, Barcelona 08908, Spain.

No abstract available